Neuroimaging in Autoimmune and Neuroinflammation-Related Epilepsies

Abstract

Autoimmune encephalitis is increasingly recognized as a cause of new onset altered mental status and seizures with a wide range of neuroimaging findings. We will describe the neuroimaging findings in autoimmune and neuroinflammation-related epilepsies.

Keywords

autoimmune - neuroinflammation - neuroimaging

• References

• 1 Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. Am J Neuroradiol 2017; 38 (06) 1070-1078
• 2 Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123 (Pt 7): 1481-1494
• 3 Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007; 13 (05) 261-271
• 4 Dalmau J, Bataller L. Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin 2006; 20 (06) 1319-1335
• 5 Florance NR, Davis RL, Lam C. , et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66 (01) 11-18
• 6 Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia 2013; 54 (06) 1036-1045
• 7 Takahashi Y, Mori H, Mishina M. , et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Epilepsia 2005; 46 (Suppl. 05) 152-158
• 8 Younes-Mhenni S, Janier MF, Cinotti L. , et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 2004; 127 (Pt 10): 2331-2338
• 9 Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013; 260 (11) 2744-2753
• 10 Lagarde S, Lepine A, Caietta E. , et al. Cerebral (18)fluorodeoxy-glucose positron emission tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: a case series. Brain Dev 2016; 38 (05) 461-470
• 11 Agarwal A, Sabat S, Thamburaj K, Kanekar S. Hippocampal changes in febrile infection-related epilepsy syndrome (fireS). Pol J Radiol 2015; 80: 391-394
• 12 van Baalen A, Häusler M, Boor R. , et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010; 51 (07) 1323-1328
• 13 Kotsenas AL, Watson RE, Pittock SJ. , et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol 2014; 35 (01) 84-89
• 14 Mantegazza R, Bernasconi P, Baggi F. , et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002; 131 (1–2): 179-185
• 15 Faria AV, Reis F, Dabus GC, Zanardi VA, Guerreiro MM, Cendes F. MRI findings in the diagnosis and monitoring of Rasmussen's encephalitis. Arq Neuropsiquiatr 2009; 67 (3B): 792-797
• 16 Pradeep K, Sinha S, Saini J. , et al. Evolution of MRI changes in Rasmussen's encephalitis. Acta Neurol Scand 2014; 130 (04) 253-259
• 17 Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair AA. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Am J Neuroradiol 2001; 22 (07) 1291-1299
• 18 Fogarasi A, Hegyi M, Neuwirth M. , et al. Comparative evaluation of concomitant structural and functional neuroimages in Rasmussen's encephalitis. J Neuroimaging 2003; 13 (04) 339-345
• 19 Kaiboriboon K, Cortese C, Hogan RE. Magnetic resonance and positron emission tomography changes during the clinical progression of Rasmussen encephalitis. J Neuroimaging 2000; 10 (02) 122-125
• 20 Lee JS, Juhász C, Kaddurah AK, Chugani HT. Patterns of cerebral glucose metabolism in early and late stages of Rasmussen's syndrome. J Child Neurol 2001; 16 (11) 798-805
• 21 Tien RD, Ashdown BC, Lewis Jr DV, Atkins MR, Burger PC. Rasmussen's encephalitis: neuroimaging findings in four patients. Am J Roentgenol 1992; 158 (06) 1329-1332
• 22 Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 2007; 4 (03) 443-452
• 23 Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006; 80 (06) 308-322
• 24 Banati RB, Myers R, Kreutzberg GWPK. PK (‘peripheral benzodiazepine’)--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol 1997; 26 (02) 77-82
• 25 Banati RB, Goerres GW, Myers R. , et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999; 53 (09) 2199-2203
• 26 Goerres GW, Revesz T, Duncan J, Banati RB. Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. Am J Roentgenol 2001; 176 (04) 1016-1018
• 27 Kumar A, Chugani HT, Luat A, Asano E, Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008; 38 (06) 439-442